433 related articles for article (PubMed ID: 25302613)
21. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis.
Artlett CM; Sassi-Gaha S; Rieger JL; Boesteanu AC; Feghali-Bostwick CA; Katsikis PD
Arthritis Rheum; 2011 Nov; 63(11):3563-74. PubMed ID: 21792841
[TBL] [Abstract][Full Text] [Related]
22. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
[TBL] [Abstract][Full Text] [Related]
23. CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.
Yoshizaki A; Iwata Y; Komura K; Ogawa F; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Tedder TF; Sato S
Am J Pathol; 2008 Jun; 172(6):1650-63. PubMed ID: 18467694
[TBL] [Abstract][Full Text] [Related]
24. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
[TBL] [Abstract][Full Text] [Related]
26. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
Ohashi T; Yamamoto T
Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
[TBL] [Abstract][Full Text] [Related]
27. Bleomycin-induced fibrosis in MC1 signalling-deficient C57BL/6J-Mc1r(e/e) mice further supports a modulating role for melanocortins in collagen synthesis of the skin.
Böhm M; Stegemann A
Exp Dermatol; 2014 Jun; 23(6):431-3. PubMed ID: 24698097
[TBL] [Abstract][Full Text] [Related]
28. Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells.
Toyama T; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Shudo K; Sato S; Kadono T
J Invest Dermatol; 2016 Feb; 136(2):387-398. PubMed ID: 26967475
[TBL] [Abstract][Full Text] [Related]
29. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.
Tomcik M; Zerr P; Pitkowski J; Palumbo-Zerr K; Avouac J; Distler O; Becvar R; Senolt L; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1215-22. PubMed ID: 23661493
[TBL] [Abstract][Full Text] [Related]
30. Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts.
Murota H; Hamasaki Y; Nakashima T; Yamamoto K; Katayama I; Matsuyama T
Arthritis Rheum; 2003 Apr; 48(4):1117-25. PubMed ID: 12687556
[TBL] [Abstract][Full Text] [Related]
31. Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.
Ponsoye M; Frantz C; Ruzehaji N; Nicco C; Elhai M; Ruiz B; Cauvet A; Pezet S; Brandely ML; Batteux F; Allanore Y; Avouac J
Ann Rheum Dis; 2016 Dec; 75(12):2142-2149. PubMed ID: 26912566
[TBL] [Abstract][Full Text] [Related]
32. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis.
Desallais L; Avouac J; Fréchet M; Elhai M; Ratsimandresy R; Montes M; Mouhsine H; Do H; Zagury JF; Allanore Y
Arthritis Res Ther; 2014 Jul; 16(4):R157. PubMed ID: 25059342
[TBL] [Abstract][Full Text] [Related]
33. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
Zhu L; Song Y; Li M
J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
[TBL] [Abstract][Full Text] [Related]
34. Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.
Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Miura S; Toyama T; Takahashi T; Ichimura Y; Yoshizaki A; Trojanowska M; Sato S
J Invest Dermatol; 2017 Mar; 137(3):631-640. PubMed ID: 27777101
[TBL] [Abstract][Full Text] [Related]
35. [Expression and significance of Th17 cells and related cytokines in a murine model of systemic sclerosis].
Lei L; Zhong XN; Zhao C; Mi CD; Li JQ; Zeng JJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):259-64. PubMed ID: 22517000
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-21a-5p inhibition alleviates systemic sclerosis by targeting STAT3 signaling.
Park JS; Kim C; Choi J; Jeong HY; Moon YM; Kang H; Lee EK; Cho ML; Park SH
J Transl Med; 2024 Apr; 22(1):323. PubMed ID: 38561750
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis.
Horn A; Kireva T; Palumbo-Zerr K; Dees C; Tomcik M; Cordazzo C; Zerr P; Akhmetshina A; Ruat M; Distler O; Beyer C; Schett G; Distler JH
Ann Rheum Dis; 2012 May; 71(5):785-9. PubMed ID: 22402139
[TBL] [Abstract][Full Text] [Related]
38. Activation of pregnane X receptor inhibits experimental dermal fibrosis.
Beyer C; Skapenko A; Distler A; Dees C; Reichert H; Munoz L; Leipe J; Schulze-Koops H; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2013 Apr; 72(4):621-5. PubMed ID: 23291432
[TBL] [Abstract][Full Text] [Related]
39. Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice.
Akashi K; Saegusa J; Sendo S; Nishimura K; Okano T; Yagi K; Yanagisawa M; Emoto N; Morinobu A
Arthritis Res Ther; 2016 May; 18(1):113. PubMed ID: 27209208
[TBL] [Abstract][Full Text] [Related]
40. Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis.
Avouac J; Elhai M; Tomcik M; Ruiz B; Friese M; Piedavent M; Colonna M; Bernhardt G; Kahan A; Chiocchia G; Distler JH; Allanore Y
Ann Rheum Dis; 2013 Jun; 72(6):1089-98. PubMed ID: 23161903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
